A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366

Clinical trial NCT03378648 · COMPLETED

Trial details

NCT number: NCT03378648
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Asthma Chronic Obstructive Pulmonary Disease

Start date: 2017-12-28
Primary completion: 2019-04-16
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.